These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 16758720

  • 1. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
    Honda M, Satoh M, Tujimoto Y, Takada T, Matsumiya K, Fujioka H.
    Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 3. [Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)].
    Maruyama T, Kondoh N, Nojima M, Yamamoto S, Mori Y, Shima H, Kamikonnya N, Hirota S, Nakao N.
    Hinyokika Kiyo; 2006 Jun; 52(6):445-9. PubMed ID: 16848358
    [Abstract] [Full Text] [Related]

  • 4. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 5. TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.
    Qureshi KN, Griffiths TR, Robinson MC, Marsh C, Roberts JT, Hall RR, Lunec J, Neal DE.
    Clin Cancer Res; 1999 Nov 01; 5(11):3500-7. PubMed ID: 10589764
    [Abstract] [Full Text] [Related]

  • 6. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun 01; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 7. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov 01; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

  • 8. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.
    Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582
    [Abstract] [Full Text] [Related]

  • 9. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M.
    BJU Int; 2006 Jan 01; 97(1):42-7. PubMed ID: 16336326
    [Abstract] [Full Text] [Related]

  • 10. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J, Diestelhorst A, Kühn R, Müller AC, Scholz HJ, Fornara P.
    Strahlenther Onkol; 2005 Oct 01; 181(10):632-7. PubMed ID: 16220401
    [Abstract] [Full Text] [Related]

  • 11. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y, Kihara K.
    Gan To Kagaku Ryoho; 2001 Nov 01; 28(12):1838-44. PubMed ID: 11729476
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun 01; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 14. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.
    Cancer; 2004 Dec 01; 101(11):2540-8. PubMed ID: 15481058
    [Abstract] [Full Text] [Related]

  • 15. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S.
    Urology; 2005 Feb 01; 65(2):295-9. PubMed ID: 15708041
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E, Climent MA, Iborra I, Collado A, Rubio J, Ricós JV, Casanova J, Calatrava A, Monrós JL.
    Eur Urol; 2009 Apr 01; 55(4):911-9. PubMed ID: 18722046
    [Abstract] [Full Text] [Related]

  • 19. [Study of the combined M-VAC therapy in invasive bladder cancer].
    Asano K, Masuda F, Suzuki H, Takamizawa S, Kaneko R.
    Hinyokika Kiyo; 1991 Dec 01; 37(12):1645-50. PubMed ID: 1785388
    [Abstract] [Full Text] [Related]

  • 20. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
    Miyanaga N, Akaza H.
    Gan To Kagaku Ryoho; 2007 Nov 01; 34(11):1745-9. PubMed ID: 18030008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.